2026 Columbus Patient and Family Conference
Saturday, October 24, 2026
Conference Co-Chairs
Uma Borate, MBBS
Alice Mims, MD
Aplastic Anemia
Xiaoyi Chen, MD, PhD
Institution
Rutgers Cancer Institute of New Jersey
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
About
Dr. Chen is currently with the Rutgers Cancer Institute, the only NCI-designated cancer center in the state, where cutting-edge cancer research is conducted and state-of-the-art cancer care is delivered. Her interest in hematological malignancies started in medical school, driving her to pursue research in this field. After graduating from West China Medical School, she joined the University of Cincinnati’s Cancer and Cell Biology program, where her primary research focused on targeting autophagy in acute leukemia and earned my PhD. Following this, she completed her internal medicine residency
Eltrombopag Added to Standard Immunosuppressive Treatment as Front-Line Therapy for Severe Aplastic Anemia: Long-Term Outcomes of the Phase-3 Randomized Superiority EBMT-SAAWP RACE Study
Original Publication Date
Article Source
External Web Content
ABSTRACT The RACE study (NCT02009747) compared horse antithymocyte globulin (hATG) plus cyclosporine A (CsA) ± eltrombopag as initial immunosuppressive treatment (IST) for severe aplastic anemia. Here we report the final 2-year analysis of this prospective randomized phase III…
Eltrombopag Added to Standard Immunosuppressive Treatment as Front-Line Therapy for Severe Aplastic Anemia: Long-Term Outcomes of the Phase-3 Randomized Superiority EBMT-SAAWP RACE Study
The RACE study (NCT02009747) compared horse antithymocyte globulin antithymocyte globulin:
Allogeneic HSCT in Aplastic Anemia: Current Evidence, Controversies, and Practical Decision-Making
Morbidity and mortality in bone marrow failure bone marrow failure:
Fueling Your Journey: Nutrition Support for Aplastic Anemia, MDS, and PNH
Topic(s)
Aplastic Anemia
Living Well with Bone Marrow Failure
Managing Your Treatment
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
In this webinar, Sondos Khattab, Registered Dietitian, will discuss practical tips for managing treatment-related challenges, food safety, and making informed nutrition choices to support overall health. Questions can be submitted in advance at help@aamds.org.
Inherited Disorders
Topic(s)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Presenter(s)
Sioban Keel, MD
Dr. Sioban Keel discusses inherited disorders, genetic testing, how these disorders are diagnosed, and their impact on treatment decisions and care.
Aplastic Anemia from the 2026 AAMDSIF Seattle Patient and Family Conference
Topic(s)
Aplastic Anemia
Presenter(s)
Sioban Keel, MD
Dr. Sioban Keel discusses the signs and symptoms of aplastic anemia, current diagnostic approaches, available treatment options, and the latest advances in patient care.